NSE · SUNPHARMA.NS
Sun Pharmaceutical Industries Limited
₹1,777.70+₹16.70 (+0.95%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 13.15% below the high.
Loading market information…
NSE · TARSONS.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 09:59 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
Tarsons Products Limited’s quoted price sits in the upper half of its reported 52-week range, 22.16% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Tarsons Products Limited’s next earnings report is currently expected on Nov 6, 2026, with estimated earnings per share of ₹4.00. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Tarsons Products Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Established in 1983 and headquartered in Kolkata, India, Tarsons Products Limited specializes in the global manufacturing and distribution of plastic laboratory supplies and scientific instruments. The company's diverse product portfolio features disposable plastic labware, centrifuge and cryogenic equipment, liquid handling systems, and safety products. Its comprehensive catalog further encompasses items such as bottles, carboys, measuring cylinders, cell culture products, electrophoresis apparatus, microscopy and microbiology tools, vacuum desiccators, mini coolers, cryo boxes, beakers, test tube racks, pipette tips, petri dishes, centrifuge tubes, cryogenic and storage vials, Pasteur pipettes, and vortex mixers, among many others. These offerings are vital for research and applications across various scientific disciplines including molecular biology, cell culture, genomics, proteomics, and immunology.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:51 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| ₹1.13B-1.62% vs estimate |
| Q3 2025 | Feb 14, 2025 | ₹1.00-23.08% vs estimate | ₹957.00M+6.97% vs estimate |
|---|
| Q2 2025 | Nov 7, 2024 | ₹1.90-17.39% vs estimate | ₹992.00M+4.53% vs estimate |
|---|
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹1,777.70+₹16.70 (+0.95%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 13.15% below the high.
₹9,780.00+₹116.00 (+1.2%)
Divi's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 0.86% below the high.
₹651.65-₹29.25 (-4.3%)
Bliss GVS Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 11.93% below the high.
₹2,309.00+₹1.40 (+0.06%)
Hester Biosciences Limited’s quoted price sits in the upper half of its reported 52-week range, 13.96% below the high.
₹19.30-₹1.11 (-5.44%)
Syncom Formulations (India) Limited’s quoted price sits in the upper half of its reported 52-week range, 29.79% below the high.
₹315.50-₹4.05 (-1.27%)
Suraksha Diagnostic Ltd.’s quoted price sits in the upper half of its reported 52-week range, 12.36% below the high.
₹215.00-₹6.94 (-3.13%)
Jagsonpal Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 18.71% below the high.
₹304.50-₹8.35 (-2.67%)
Bajaj Healthcare Ltd’s quoted price sits in the lower half of its reported 52-week range, 37.72% below the high.
